JS207

Other Medications

EU Experimental ES Not available 2 Clinical Trials

Description

JS207 is an experimental medication currently being studied in clinical trials for colorectal cancer. It is being investigated as a potential treatment option for advanced colorectal cancer, specifically in patients whose tumors are microsatellite stable (MSS) or have deficient mismatch repair (pMMR). The trials are evaluating JS207 in combination with standard chemotherapy (XELOX, which is capecitabine and oxaliplatin) and sometimes with another experimental drug called JS015. The goal of these Phase 2 trials is to determine the safety and effectiveness of JS207 in this setting. It is not yet approved for use in colorectal cancer.

Mechanism of Action

JS207 is being studied in combination with chemotherapy for advanced colorectal cancer. The specific way JS207 works (its mechanism of action) is not fully detailed in the available information, but it is being investigated alongside other drugs to potentially improve treatment outcomes. It is being tested in patients with MSS/pMMR tumors.

Side Effects

As JS207 is an investigational drug Its side effects are still being evaluated in ongoing clinical trials. The specific side effects associated with JS207 in combination with chemotherapy are being closely monitored by researchers in the trials to determine its safety profile.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT07503756 Phase 2
Recruiting
JS212 Combination Therapies in Metastatic Colorectal Cancer
China
NCT06885385 Phase 2
Recruiting
A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer
China

Quick Info

CategoryOther Medications
EU EMA StatusExperimental
ES Spain AccessNot available
Clinical Trials2
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
768 trials
Leucovorin
Other Medications
627 trials
Trifluridine
Other Medications
45 trials
Paclitaxel
Other Medications
43 trials
Cyclophosphamid
Other Medications
40 trials
Cyclophosphamide
Other Medications
39 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.